Inventor
MCTAVISH HUGH
US27 patents
⚠️ This page may combine multiple inventors who share the name “MCTAVISH HUGH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IGF ONCOLOGY LLC
7 patentsUS8017102B2Sep 13, 2011
Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer
IGF ONCOLOGY LLC8 citations83
US7811982B2Oct 12, 2010
Compounds and methods for treating cancer
IGF ONCOLOGY LLC11 citations83
US10967049B2Apr 6, 2021
Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
IGF ONCOLOGY LLC2 citations72
US10391147B2Aug 27, 2019
Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
IGF ONCOLOGY LLC2 citations72
US9801923B2Oct 31, 2017
Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
IGF ONCOLOGY LLC2 citations72
US11324834B2May 10, 2022
Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome
IGF ONCOLOGY LLC2 citations66
US12527876B2Jan 20, 2026
Insulin-like growth factor-chemotherapeutic conjugate for treating myelodysplastic syndrome
IGF ONCOLOGY LLC0 citations55
MCTAVISH HUGH
6 patentsUS7608439B2Oct 27, 2009
Bio-recycling of carbon dioxide emitted from power plants
MCTAVISH HUGH34 citations90
US9675671B2Jun 13, 2017
Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
MCTAVISH HUGH3 citations72
US9011880B2Apr 21, 2015
Compounds and methods for treating cancer
MCTAVISH HUGH2 citations62
US8501906B2Aug 6, 2013
Compounds and methods for treating cancer
MCTAVISH HUGH4 citations62
US8016700B2Sep 13, 2011
Tennis backboard
MCTAVISH HUGH4 citations61
US8920777B2Dec 30, 2014
Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer
MCTAVISH HUGH0 citations51
SQUAREX LLC
6 patentsUS10940197B2Mar 9, 2021
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
SQUAREX LLC2 citations72
US10245314B2Apr 2, 2019
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
SQUAREX LLC1 citations72
US9205065B2Dec 8, 2015
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
SQUAREX LLC4 citations69
US12128098B2Oct 29, 2024
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
SQUAREX LLC0 citations61
US11957783B2Apr 16, 2024
Topical immunosensitizers to treat viral and fungal infections
SQUAREX LLC0 citations59
US10744084B2Aug 18, 2020
Non-specific delayed-type hypersensitivity response to treat herpes simplex virus infection
SQUAREX LLC0 citations48